CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)

Author: 
Reena Sinha, Nishi, Verma, P. K. and Jha, P. C.
Subject Area: 
Health Sciences
Abstract: 

Introduction: Carcinoma breast is one of the commonest cancer in women, both in western world and in developing countries like India. Breast carcinoma is a hormone dependant disease. Immunohistochemical prognostic and predictive markers ER, PR and Her2/neu significantly influences prognosis, survival and selection of therapy in female breast cancer cases. Aim and objective: The purpose of this study was (i) to evaluate the prevalence of prognostic and predictive markers ER, PR and Her2/ neu by immunohistochemistry in female carcinoma breast cases in Bihar (Northern India), (ii) to compare the pattern of expression of these markers with age of the patients & (iii) to correlate the ER, PR & Her2/neu expressions with each other. Materials and Methods: This prospective study was carried out in Department of Pathology, Mahavir Cancer Sansthan and Research Centre, Phulwarisharif in between March 2015 to December 2016. 412 female carcinoma breast cases diagnosed by radiology and FNAC and further confirmed by histopathological examination of biopsy were included in this study. Immunohistochemical staining for ER, PR and Her2/neu were done in all 412 cases of female carcinoma breast. Results: Immunohistochemical markers ER and PR were found positive in 210 (50.97%) and 234(56.49%) cases respectively. Her2/neu was found positive in 148 (35.92%) cases. The Mean± SEM age of the patient in this study was 47.63 ± 0.549 years. Triple negative breast cancer which had poor prognosis was found in only 16 (3.88 %) cases. Conclusion: In conclusion, the prevalence of ER, PR and Her2/net over expression in our study does not fall within the ranges given in most of the literature. Our results showed higher proportion of ER, PR and Her2/ neu over expression in comparison to most of the studies. Fortunately our results also showed lower proportion of triple-negative breast cancer cases having poor prognosis. The findings suggest that North Indian women in the Bihar have breast carcinoma comparatively at younger age, likely to be more susceptible to conventional hormonal and targeted antibody treatment.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR

Rosane Cavalcante Fragoso, Brasil

ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran